MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 57 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | -63.7% | 650 | 0.0% | 0.00% | – |
| Q2 2023 | $234 | -76.6% | 650 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 650 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 650 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 650 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 650 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 650 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
| Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
| IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
| Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
| BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
| Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |